Prognostic factors other than the performance status and age for glioblastoma multiforme: a single-institution experience
Küçük Resim Yok
Tarih
2009
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Imprimatur Publications
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Purpose: To evaluate the survival of patients with glioblastoma multiforme (GBM) and analyse the prognostic Actors influencing survival. Patients and methods: Seventy-eight consecutive patients with GBM treated with radiotherapy (RT) and temozolomide (TMZ) (in 21 patients) between 1999 and 2006 were retrospectively analysed. Results: Sixty-seven (85.5%) patients had undergone gross total or subtotal resection before RT The median overall survival was 9.8 months, and significantly influenced by age (p=0.02), Karnofsky performance status (p=0.001), RT (p<0.0001), gender (p=0.02), concomitant TMZ (p=0.003), RT waiting time (p=0.014), and treatment time (p=0.01) in univariate analysis. In multivariate analysis, older age (p=0.03), male gender (p=0.01), absence of concomitant TMZ (p=0.008), RT dose below 60 Gy (p=0.03), RT waiting time more than 20 days (p=0.01), and treatment time more than 76 days (p=0.0072) were poor prognosticators. Conclusion: This study emphasizes the importance of female gender, dose and duration of RT and RT waiting time in patients with glioblastoma multiforme.
Açıklama
Anahtar Kelimeler
Chemotherapy, Gender, Glioblastoma Multiforme, Prognostic Factors, Radiotherapy, Survival, Growth-Factor Receptor, Multivariate-Analysis, Adjuvant Temozolomide, Malignant Gliomas, Survival-Time, Radiotherapy, Resection, Irradiation, Oncology, Therapy
Kaynak
Journal Of Buon
WoS Q Değeri
Q4
Scopus Q Değeri
Q3
Cilt
14
Sayı
2
